• Info
  • Insider Ownership

Insider Trading & Ownership of Jeffrey Eisele

Location
Waltham, MA
Summary
The estimated net worth of Jeffrey Eisele is at least $1.63M dollars as of 30 Jan 2025. Jeffrey Eisele is the Chief Development Officer of Apellis Pharmaceuticals, Inc. and owns shares of Apellis Pharmaceuticals, Inc. (APLS) stock worth about $1.63M.
Signature
/s/ David Watson, attorney-in-fact for Jeffrey Eisele
All Insider Reports
All Insider Reports

Notify me when Jeffrey Eisele files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Jeffrey Eisele

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
APLS Apellis Pharmaceuticals, Inc. Chief Development Officer $1.63M -$55.1K -3.26% 29 Jan 2025

Insider Transactions Reported by Jeffrey Eisele:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.